The 15-Lipoxygenase-1 Product 13-S-Hydroxyoctadecadienoic Acid Down-Regulates PPAR-δ to Induce Apoptosis in Colorectal Cancer Cells

Diminished apoptosis, a critical event in tumorigenesis, is linked to down-regulated 15-lipoxygenase-1 (15-LOX-1) expression in colorectal cancer cells. 13-S-hydroxyoctadecadienoic acid (13-S-HODE), which is the primary product of 15-LOX-1 metabolism of linoleic acid, restores apoptosis. Nonsteroida...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 100; no. 17; pp. 9968 - 9973
Main Authors Shureiqi, Imad, Jiang, Wei, Zuo, Xiangsheng, Wu, Yuanqing, Stimmel, Julie B., Leesnitzer, Lisa M., Morris, Jeffrey S., Fan, Hui-Zhen, Fischer, Susan M., Lippman, Scott M.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 19.08.2003
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Diminished apoptosis, a critical event in tumorigenesis, is linked to down-regulated 15-lipoxygenase-1 (15-LOX-1) expression in colorectal cancer cells. 13-S-hydroxyoctadecadienoic acid (13-S-HODE), which is the primary product of 15-LOX-1 metabolism of linoleic acid, restores apoptosis. Nonsteroidal antiinflammatory drugs (NSAIDs) transcriptionally up-regulate 15-LOX-1 expression to induce apoptosis. Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors for linoleic and arachidonic acid metabolites. PPAR-δ promotes colonic tumorigenesis. NSAIDs suppress PPAR-δ activity in colon cancer cells. The mechanistic relationship between 15-LOX-1 and PPAR-δ was previously unknown. Our current study shows that (i) 13-S-HODE binds to PPAR-δ, decreases PPAR-δ activation, and down-regulates PPAR-α expression in colorectal cancer cells; (ii) the induction of 15-LOX-1 expression is a critical step in NSAID down-regulation of PPAR-δ and the resultant induction of apoptosis; and (iii) PPAR-δ is an important signaling receptor for 13-S-HODE-induced apoptosis. The in vivo relevance of these mechanistic findings was demonstrated in our tumorigenesis studies in nude mouse xenograft models. Our findings indicate that the down-regulation of PPARδ by 15-LOX-1 through 13-S-HODE is an apoptotic signaling pathway that is activated by NSAIDs.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: 13-S-HODE, 13-S-hydroxyoctadecadienoic acid; 15-LOX-1, 15-lipoxygenase-1; AS, antisense; β-gal, β-galactosidase; COX, cyclooxygenase; E-RKO, pcDNA3.1 empty-vector-transfected RKO cells; LBD, ligand-binding domain; NSAIDs, nonsteroidal antiinflammatory drugs; PPARs, peroxisome proliferator-activated receptors; TUNEL, terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling; W-RKO, WT RKO cells.
To whom correspondence should be addressed. E-mail: ishureiqi@mdanderson.org.
Edited by Bert Vogelstein, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, and approved June 11, 2003
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1631086100